J Loper, JF, R Lutes, EJ Baltes, RK May, JT Broyles, RA Heuberger, RL Atkinson.
Recent Posts
- Ongoing Research: Effects of VLCD and Drug Treatment for Obesity. (Protocol I. Protocol F. CONCI)
- Welcome to CONCI
- Five-year Maintenance Results of an Obesity Drug Following a Very Low Calorie Diet (VLCD) Presented at Obesity Week, 2013
- Naltrexone SR/Bupropion SR Combination Therapy Reduces Total and Visceral Adiposity in Overweight and Obese Subjects in the COR-1 Study. American Diabetes Association, 2011.
- Naltrexone SR/Bupropion SR Therapy Reduced Body Weight and HgbA1C in Overweight/Obese Women with Type 2 Diabetes. American Diabetes Association, 2011.
Recent Comments
No comments to show.